Sormani MP, Häring DA, Kropshofe H, et al. Blood NfL as a potential endpoint in Phase 2 clinical studies in relapsing-remitting multiple sclerosis. ECTRIMS 2017, #277.
ECTRIMS 2015 video update Teunissen: Will MS be prevented?
jun 2017
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen